3.40 USD
▲+0.05+6.92%
盘后 3.16 -0.63%
2026-08-03
市值
$1.02B
市盈率
—
EPS
-0.92
股息率
—
52 周区间
2.61 – 6.55
成交量
1.71M
Beta
2.10
目标价
8.57
52W 低 2.6152W 高 6.55
价格走势
公司简介
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company’s product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modified, stem cell derived pancreatic islet cell therap...